A citation-based method for searching scientific literature

Laurent Castera, Mireen Friedrich-Rust, Rohit Loomba. Gastroenterology 2019
Times Cited: 534







List of co-cited articles
887 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Zobair M Younossi, Aaron B Koenig, Dinan Abdelatif, Yousef Fazel, Linda Henry, Mark Wymer. Hepatology 2016
43

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
Naga Chalasani, Zobair Younossi, Joel E Lavine, Michael Charlton, Kenneth Cusi, Mary Rinella, Stephen A Harrison, Elizabeth M Brunt, Arun J Sanyal. Hepatology 2018
36


The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.
Paul Angulo, Jason M Hui, Giulio Marchesini, Ellisabetta Bugianesi, Jacob George, Geoffrey C Farrell, Felicity Enders, Sushma Saksena, Alastair D Burt, John P Bida,[...]. Hepatology 2007
27

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.
Zobair Younossi, Quentin M Anstee, Milena Marietti, Timothy Hardy, Linda Henry, Mohammed Eslam, Jacob George, Elisabetta Bugianesi. Nat Rev Gastroenterol Hepatol 2018
25

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.
Richard K Sterling, Eduardo Lissen, Nathan Clumeck, Ricard Sola, Mendes Cassia Correa, Julio Montaner, Mark S Sulkowski, Francesca J Torriani, Doug T Dieterich, David L Thomas,[...]. Hepatology 2006
25

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.
Paul Angulo, David E Kleiner, Sanne Dam-Larsen, Leon A Adams, Einar S Bjornsson, Phunchai Charatcharoenwitthaya, Peter R Mills, Jill C Keach, Heather D Lafferty, Alisha Stahler,[...]. Gastroenterology 2015
24

Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
David E Kleiner, Elizabeth M Brunt, Mark Van Natta, Cynthia Behling, Melissa J Contos, Oscar W Cummings, Linda D Ferrell, Yao-Chang Liu, Michael S Torbenson, Aynur Unalp-Arida,[...]. Hepatology 2005
24

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.
Mohammed Eslam, Philip N Newsome, Shiv K Sarin, Quentin M Anstee, Giovanni Targher, Manuel Romero-Gomez, Shira Zelber-Sagi, Vincent Wai-Sun Wong, Jean-François Dufour, Jörn M Schattenberg,[...]. J Hepatol 2020
21

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Peter J Eddowes, Magali Sasso, Michael Allison, Emmanouil Tsochatzis, Quentin M Anstee, David Sheridan, Indra N Guha, Jeremy F Cobbold, Jonathan J Deeks, Valérie Paradis,[...]. Gastroenterology 2019
424
20

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.
Parambir S Dulai, Siddharth Singh, Janki Patel, Meera Soni, Larry J Prokop, Zobair Younossi, Giada Sebastiani, Mattias Ekstedt, Hannes Hagstrom, Patrik Nasr,[...]. Hepatology 2017
876
19


Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.
Stuart McPherson, Tim Hardy, Jean-Francois Dufour, Salvatore Petta, Manuel Romero-Gomez, Mike Allison, Claudia P Oliveira, Sven Francque, Luc Van Gaal, Jörn M Schattenberg,[...]. Am J Gastroenterol 2017
322
18

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population.
Giorgio Bedogni, Stefano Bellentani, Lucia Miglioli, Flora Masutti, Marilena Passalacqua, Anna Castiglione, Claudio Tiribelli. BMC Gastroenterol 2006
16

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.
Thomas Karlas, David Petroff, Magali Sasso, Jian-Gao Fan, Yu-Qiang Mi, Victor de Lédinghen, Manoj Kumar, Monica Lupsor-Platon, Kwang-Hyub Han, Ana C Cardoso,[...]. J Hepatol 2017
463
16

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.
Mattias Ekstedt, Hannes Hagström, Patrik Nasr, Mats Fredrikson, Per Stål, Stergios Kechagias, Rolf Hultcrantz. Hepatology 2015
16

Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease.
Ankur Srivastava, Ruth Gailer, Sudeep Tanwar, Paul Trembling, Julie Parkes, Alison Rodger, Deepak Suri, Douglas Thorburn, Karen Sennett, Sarah Morgan,[...]. J Hepatol 2019
184
16

Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis.
Ruben Hernaez, Mariana Lazo, Susanne Bonekamp, Ihab Kamel, Frederick L Brancati, Eliseo Guallar, Jeanne M Clark. Hepatology 2011
823
15


Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.
Amy G Shah, Alison Lydecker, Karen Murray, Brent N Tetri, Melissa J Contos, Arun J Sanyal. Clin Gastroenterol Hepatol 2009
780
14

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.
Eduardo Vilar-Gomez, Yadina Martinez-Perez, Luis Calzadilla-Bertot, Ana Torres-Gonzalez, Bienvenido Gra-Oramas, Licet Gonzalez-Fabian, Scott L Friedman, Moises Diago, Manuel Romero-Gomez. Gastroenterology 2015
14

Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.
Siddharth Singh, Alina M Allen, Zhen Wang, Larry J Prokop, Mohammad H Murad, Rohit Loomba. Clin Gastroenterol Hepatol 2015
837
14

Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Rod S Taylor, Rebecca J Taylor, Sue Bayliss, Hannes Hagström, Patrik Nasr, Jorn M Schattenberg, Masatoshi Ishigami, Hidenori Toyoda, Vincent Wai-Sun Wong, Noam Peleg,[...]. Gastroenterology 2020
315
14

Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease.
Jeong-Hoon Lee, Donghee Kim, Hwa Jung Kim, Chang-Hoon Lee, Jong In Yang, Won Kim, Yoon Jun Kim, Jung-Hwan Yoon, Sang-Heon Cho, Myung-Whun Sung,[...]. Dig Liver Dis 2010
566
12

The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.
Zobair M Younossi, Pegah Golabi, Leyla de Avila, James Minhui Paik, Manirath Srishord, Natsu Fukui, Ying Qiu, Leah Burns, Arian Afendy, Fatema Nader. J Hepatol 2019
647
12

Noninvasive biomarkers in NAFLD and NASH - current progress and future promise.
Vincent Wai-Sun Wong, Leon A Adams, Victor de Lédinghen, Grace Lai-Hung Wong, Silvia Sookoian. Nat Rev Gastroenterol Hepatol 2018
259
12

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
Kento Imajo, Takaomi Kessoku, Yasushi Honda, Wataru Tomeno, Yuji Ogawa, Hironori Mawatari, Koji Fujita, Masato Yoneda, Masataka Taguri, Hideyuki Hyogo,[...]. Gastroenterology 2016
440
12

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.
Jérôme Boursier, Julien Vergniol, Anne Guillet, Jean-Baptiste Hiriart, Adrien Lannes, Brigitte Le Bail, Sophie Michalak, Faiza Chermak, Sandrine Bertrais, Juliette Foucher,[...]. J Hepatol 2016
208
12

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.
Chun-Tao Wai, Joel K Greenson, Robert J Fontana, John D Kalbfleisch, Jorge A Marrero, Hari S Conjeevaram, Anna S-F Lok. Hepatology 2003
12

MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.
Mohammed Eslam, Arun J Sanyal, Jacob George. Gastroenterology 2020
990
11

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study.
Philip N Newsome, Magali Sasso, Jonathan J Deeks, Angelo Paredes, Jérôme Boursier, Wah-Kheong Chan, Yusuf Yilmaz, Sébastien Czernichow, Ming-Hua Zheng, Vincent Wai-Sun Wong,[...]. Lancet Gastroenterol Hepatol 2020
202
11

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.
Hannes Hagström, Patrik Nasr, Mattias Ekstedt, Ulf Hammar, Per Stål, Rolf Hultcrantz, Stergios Kechagias. J Hepatol 2017
467
11

Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants.
Cynthia Hsu, Cyrielle Caussy, Kento Imajo, Jun Chen, Siddharth Singh, Kellee Kaulback, Minh-Da Le, Jonathan Hooker, Xin Tu, Ricki Bettencourt,[...]. Clin Gastroenterol Hepatol 2019
156
11

Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease.
Paul Angulo, Elisabetta Bugianesi, Einar S Bjornsson, Phunchai Charatcharoenwitthaya, Peter R Mills, Francisco Barrera, Svanhildur Haflidadottir, Christopher P Day, Jacob George. Gastroenterology 2013
320
11

Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials.
Beth A Davison, Stephen A Harrison, Gad Cotter, Naim Alkhouri, Arun Sanyal, Christopher Edwards, Jerry R Colca, Julie Iwashita, Gary G Koch, Howard C Dittrich. J Hepatol 2020
114
11

Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials.
Quentin M Anstee, Eric J Lawitz, Naim Alkhouri, Vincent Wai-Sun Wong, Manuel Romero-Gomez, Takeshi Okanoue, Michael Trauner, Kathryn Kersey, Georgia Li, Ling Han,[...]. Hepatology 2019
127
11

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
Eduardo Vilar-Gomez, Luis Calzadilla-Bertot, Vincent Wai-Sun Wong, Marlen Castellanos, Rocio Aller-de la Fuente, Mayada Metwally, Mohammed Eslam, Licet Gonzalez-Fabian, María Alvarez-Quiñones Sanz, Antonio Felix Conde-Martin,[...]. Gastroenterology 2018
360
10

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.
Philip N Newsome, Kristine Buchholtz, Kenneth Cusi, Martin Linder, Takeshi Okanoue, Vlad Ratziu, Arun J Sanyal, Anne-Sophie Sejling, Stephen A Harrison. N Engl J Med 2021
357
10


Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis.
Yasaman Vali, Jenny Lee, Jérôme Boursier, René Spijker, Jürgen Löffler, Joanne Verheij, M Julia Brosnan, Zsolt Böcskei, Quentin M Anstee, Patrick M Bossuyt,[...]. J Hepatol 2020
84
11


Treatment of NAFLD with diet, physical activity and exercise.
Manuel Romero-Gómez, Shira Zelber-Sagi, Michael Trenell. J Hepatol 2017
527
10

Sampling variability of liver biopsy in nonalcoholic fatty liver disease.
Vlad Ratziu, Frédéric Charlotte, Agnès Heurtier, Sophie Gombert, Philippe Giral, Eric Bruckert, André Grimaldi, Frédérique Capron, Thierry Poynard. Gastroenterology 2005
10

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.
Giovanni Targher, Christopher D Byrne, Amedeo Lonardo, Giacomo Zoppini, Corrado Barbui. J Hepatol 2016
664
9

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
Arun J Sanyal, Naga Chalasani, Kris V Kowdley, Arthur McCullough, Anna Mae Diehl, Nathan M Bass, Brent A Neuschwander-Tetri, Joel E Lavine, James Tonascia, Aynur Unalp,[...]. N Engl J Med 2010
9

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study.
Matthew James Armstrong, Piers Gaunt, Guruprasad P Aithal, Darren Barton, Diana Hull, Richard Parker, Jonathan M Hazlehurst, Kathy Guo, George Abouda, Mark A Aldersley,[...]. Lancet 2016
944
9

Liver biopsy.
Don C Rockey, Stephen H Caldwell, Zachary D Goodman, Rendon C Nelson, Alastair D Smith. Hepatology 2009
9

NAFLD: a multisystem disease.
Christopher D Byrne, Giovanni Targher. J Hepatol 2015
9

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.
Stefano Romeo, Julia Kozlitina, Chao Xing, Alexander Pertsemlidis, David Cox, Len A Pennacchio, Eric Boerwinkle, Jonathan C Cohen, Helen H Hobbs. Nat Genet 2008
9

Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.
Daniel Q Huang, Hashem B El-Serag, Rohit Loomba. Nat Rev Gastroenterol Hepatol 2021
353
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.